ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Judith Salerno Named President and CEO of Komen

June 21, 2013

CHOP Training Conference Planned

January 23, 1981

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

March 4, 1988

In Brief: DeVita Changes His Mind, Agrees To Head Treatment DIV; Contracts Chief Carl Fretts Moves Up To NIH

October 4, 1974

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009